Cette étude de 3 ans menée sur le tirzépatide, par une équipe du Comprehensive Weight Control Center de la Weill Cornell ...

Lipozem reviews on Reddit present a mixed yet informative perspective on this natural weight loss supplement. Users ...

PrimeBiome is a gut-focused supplement formulated to help improve skin clarity, support healthier digestion, and foster an ...

Accèdez sans limite aux 15 000 actualités du site et recevez gratuitement chaque semaine, la Newsletter Santé log avec les ...

Pursuant to the New OTBC Service Agreement, OTBC will be paid $100,000 in cash, which shall be payable in quarterly installments over 12 months, and receive an option pursuant to the Company’s stock ...

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.

DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société ...

The filing, for the year ended December 31, 2024, of its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission (“SEC”) and its Universal Registration Document (“URD”) with the ...

This release has been authorised by the directors of Immuron Limited. Steven Lydeamore Chief Executive Officer ...

Dr. Aljurf is the first recipient from outside the United States, underscoring his global impact on hematopoietic stem cell ...

Fulcrum granted the new employees an aggregate of 96,800 options to purchase shares of the company’s common stock at an exercise price of $2.72 per share, the closing price per share of Fulcrum’s ...

BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that on April 9, 2025, the compensation ...